Levensohn Venture Partners currently advises and co-manages three early stage venture capital funds with over 50 active direct portfolio investments. These funds follow three prior venture funds that invested over $200 million in emerging companies since the firm’s inception in 1996.

Pascal Levensohn has advised the Dolby family since 2011 and is currently the Senior Managing Director of Dolby Family Ventures. In partnership with Dave Dolby, Pascal co-manages the Dolby family’s direct investment platform, which is focused on breakthrough, early stage opportunities in augmented and virtual reality, advanced digital signal processing, aerospace, security, and neurodegeneration.

Pascal is currently the Chairman of the Board of ShotSpotter, Inc. (NASDAQ:SSTI), Chairman of the board of NativeWaves GmbH (Salzburg, Austria), Vice Chairman of the board of Authentic Vision GmbH (Salzburg, Austria), a director of Mixed Dimensions, Inc. (San Francisco), a director of GenomSys, SA (Lausanne, Switzerland), a director of Therini Bio, Inc. (San Francisco), and a director of Cure Network Dolby Acceleration Partners LLC (San Francisco). He is a formal board observer at Strateos and Kuprion. He has served as board chairman, audit committee chairman, compensation committee chairman, and board secretary for venture-backed companies since 1996 and first served as a public company director in 1993.